Talphera Expects Registrational NEPHRO CRRT Study To Be Completed By The End Of 2025
Benzinga Newsdesk 1 year ago
News
Cash and investments at December 31, 2024 of $8.9 million, together with the private placement financing recently announced of up to $14.8 million, expected to provide capital through target completion of the NEPHRO
Cash and investments at December 31, 2024 of $8.9 million, together with the private placement financing recently announced of up to $14.8 million, expected to provide capital through target completion of the NEPHRO study in the fourth quarter of 2025.